home / stock / pvct / pvct quote
Last: | $0.1189 |
---|---|
Change Percent: | -10.74% |
Open: | $0.1196 |
Close: | $0.1189 |
High: | $0.1196 |
Low: | $0.11 |
Volume: | 23,466 |
Last Trade Date Time: | 07/17/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.1189 | $0.1196 | $0.1189 | $0.1196 | $0.11 | 23,466 | 07-17-2024 |
$0.108 | $0.1148 | $0.108 | $0.1148 | $0.108 | 165,277 | 07-16-2024 |
$0.1147 | $0.1168 | $0.1147 | $0.12 | $0.10998 | 202,363 | 07-15-2024 |
$0.116832 | $0.1144 | $0.116832 | $0.1259 | $0.1084 | 374,104 | 07-12-2024 |
$0.109 | $0.1282 | $0.109 | $0.1282 | $0.1023 | 1,277,857 | 07-11-2024 |
$0.13 | $0.1486 | $0.13 | $0.1486 | $0.13 | 380,862 | 07-10-2024 |
$0.1485 | $0.13765 | $0.1485 | $0.1495 | $0.136 | 196,592 | 07-09-2024 |
$0.135 | $0.1352 | $0.135 | $0.14048 | $0.135 | 299,727 | 07-08-2024 |
$0.13 | $0.1234 | $0.13 | $0.14 | $0.1234 | 347,260 | 07-05-2024 |
$0.12735 | $0.1314 | $0.12735 | $0.1314 | $0.1218 | 152,444 | 07-02-2024 |
$0.13165 | $0.12626 | $0.13165 | $0.134 | $0.1206 | 387,219 | 07-01-2024 |
$0.1261 | $0.1305 | $0.1261 | $0.134821 | $0.1261 | 319,198 | 06-28-2024 |
$0.135 | $0.147 | $0.135 | $0.1494 | $0.1251 | 298,482 | 06-27-2024 |
$0.148375 | $0.1495 | $0.148375 | $0.1495 | $0.147 | 10,895 | 06-26-2024 |
$0.147 | $0.1495 | $0.147 | $0.1495 | $0.14 | 115,153 | 06-25-2024 |
$0.140085 | $0.1431 | $0.140085 | $0.15 | $0.14 | 46,255 | 06-24-2024 |
$0.15675 | $0.1475 | $0.15675 | $0.1595 | $0.1475 | 31,359 | 06-21-2024 |
$0.1484 | $0.1515 | $0.1484 | $0.15825 | $0.143 | 132,191 | 06-20-2024 |
$0.158 | $0.1585 | $0.158 | $0.1585 | $0.1506 | 55,237 | 06-19-2024 |
$0.158 | $0.1585 | $0.158 | $0.1585 | $0.150625 | 55,237 | 06-18-2024 |
News, Short Squeeze, Breakout and More Instantly...
Provectus Biopharmaceuticals Inc Company Name:
PVCT Stock Symbol:
OTCMKTS Market:
Provectus Biopharmaceuticals Inc Website:
KNOXVILLE, Tenn., June 13, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) announced today that its 2024 annual stockholder meeting (the “2024 Annual Meeting”), including meeting activities and ...
Accelerates wound closure and improves wound healing KNOXVILLE, TN, May 21, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that non-clinical data on Provectus’s proprietary, pharma...
PDAT clinical outcomes for infectious keratitis from Brazil and Mexico KNOXVILLE, TN, May 14, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that clinical and non-clinical data on rose be...